2.4.0.8170 - Disclosure - Schedule of Net Amount of Risk by Product and Guarantee (Detail)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$eol_PE715633--1310-Q0007_STD_91_20130630_0http://www.sec.gov/CIK0001369786duration2013-04-01T00:00:002013-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$eol_PE715633--1310-Q0007_STD_91_20120630_0http://www.sec.gov/CIK0001369786duration2012-04-01T00:00:002012-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$eol_PE715633--1310-Q0007_STD_181_20130630_0http://www.sec.gov/CIK0001369786duration2013-01-01T00:00:002013-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$eol_PE715633--1310-Q0007_STD_182_20120630_0http://www.sec.gov/CIK0001369786duration2012-01-01T00:00:002012-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 3us-gaap_ProductInformationLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Product Information [Line Items]2false 4us-gaap_SalesRevenueGoodsNetus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse5959100059591USD$falsetruefalse2truefalsefalse4268000042680USD$falsetruefalse3truefalsefalse119802000119802USD$falsetruefalse4truefalsefalse8096000080960USD$falsetruefalsexbrli:monetaryItemTypemonetaryAggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1(a)) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 false2Net revenue by Product Line3false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5false USDtruefalse$eol_PE715633--1310-Q0007_STD_91_20130630_0_709205x816834http://www.sec.gov/CIK0001369786duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseAnti-infectiveus-gaap_ProductOrServiceAxisxbrldihttp://xbrl.org/2006/xbrldisgnt_AntiInfectiveMemberus-gaap_ProductOrServiceAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Anti-infective4true 3us-gaap_ProductInformationLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Product Information [Line Items]5false 4us-gaap_SalesRevenueGoodsNetus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse1971700019717USD$falsefalsefalse2truefalsefalse2189400021894USD$falsefalsefalse3truefalsefalse4189500041895USD$falsefalsefalse4truefalsefalse3914100039141USD$falsefalsefalsexbrli:monetaryItemTypemonetaryAggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1(a)) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 false2Net revenue by Product Line6false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse9false USDtruefalse$eol_PE715633--1310-Q0007_STD_91_20130630_0_709205x742211http://www.sec.gov/CIK0001369786duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseCritical careus-gaap_ProductOrServiceAxisxbrldihttp://xbrl.org/2006/xbrldisgnt_CriticalCareMemberus-gaap_ProductOrServiceAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Critical care7true 3us-gaap_ProductInformationLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Product Information [Line Items]8false 4us-gaap_SalesRevenueGoodsNetus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse1367000013670USD$falsefalsefalse2truefalsefalse1547700015477USD$falsefalsefalse3truefalsefalse3274400032744USD$falsefalsefalse4truefalsefalse3298800032988USD$falsefalsefalsexbrli:monetaryItemTypemonetaryAggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1(a)) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 false2Net revenue by Product Line9false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse13false USDtruefalse$eol_PE715633--1310-Q0007_STD_91_20130630_0_709205x733364http://www.sec.gov/CIK0001369786duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseOncologyus-gaap_ProductOrServiceAxisxbrldihttp://xbrl.org/2006/xbrldisgnt_OncologyMemberus-gaap_ProductOrServiceAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Oncology10true 3us-gaap_ProductInformationLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Product Information [Line Items]11false 4us-gaap_SalesRevenueGoodsNetus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse2620400026204USD$falsetruefalse2truefalsefalse53090005309USD$falsetruefalse3truefalsefalse4516300045163USD$falsetruefalse4truefalsefalse88310008831USD$falsetruefalsexbrli:monetaryItemTypemonetaryAggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1(a)) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 false2Net revenue by Product LinefalseSchedule of Net Amount of Risk by Product and Guarantee (Detail) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.sagentpharma.com/taxonomy/role/DisclosureScheduleOfNetAmountOfRiskByProductAndGuarantee411